Liquid Biopsy and Circulating Biomarkers: The Future of Early Cancer Detection
The greatest opportunity in oncology may not lie in discovering another drug, but in diagnosing cancer before treatment becomes difficult [1]. While there have been significant advances in imaging, molecular pathology, and targeted therapies, many malignancies are still identified when symptoms have developed or when m...